Cargando…
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis
INTRODUCTION: Risk of adverse effects and flare of inflammatory bowel disease (IBD) are frequently cited reasons for COVID-19 vaccine hesitancy. METHODS: Electronic databases were searched to identify studies reporting the use of COVID-19 vaccine in IBD. We selected studies reporting the incidence o...
Autores principales: | James, Deepak, Jena, Anuraag, Bharath, Pardhu Neelam, Choudhury, Arup, Singh, Anupam K., Sebastian, Shaji, Sharma, Vishal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938236/ https://www.ncbi.nlm.nih.gov/pubmed/35382972 http://dx.doi.org/10.1016/j.dld.2022.03.005 |
Ejemplares similares
-
Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis
por: Choudhury, Arup, et al.
Publicado: (2022) -
Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis
por: Jena, Anuraag, et al.
Publicado: (2022) -
Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis
por: Singh, Anupam Kumar, et al.
Publicado: (2021) -
Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults
por: Dai, Yun-Kai, et al.
Publicado: (2020) -
The Impact of Obesity on the Clinical Course of Inflammatory Bowel Disease: A Meta-Analysis
por: Hu, Qiongyuan, et al.
Publicado: (2017)